Significant Ownership of Frazier Life Sciences Public Fund, L.P.

Signature - Title
/s/ Jennifer Martin - By Jennifer, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Frazier Life Sciences Public Fund, L.P..

Notify me when Frazier Life Sciences Public Fund, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Frazier Life Sciences Public Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MBX MBX BIOSCIENCES, INC. Common Stock, $0.0001 par value per share 12% $72,562,680 +$9,264,602 5,224,095 +15% Patrick J. Heron 26 Sep 2025
MAZE Maze Therapeutics, Inc. Common Stock - par value $0.001 per share 9% $174,515,671 +$39,762,017 4,342,266 +30% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
IBIO iBio, Inc. Common Stock, $0.001 par value per share 8.7% $2,344,160 1,953,467 Frazier Life Sciences Public Fund, L.P. 09 Dec 2025
PHAT PHATHOM PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share 8.6% $70,447,299 5,985,327 0% James N. Topper 01 Nov 2025
NAMS NEWAMSTERDAM PHARMA COMPANY N.V. Ordinary Shares, nominal value EUR0.12 per share 7.7% $245,264,825 +$36,858,297 8,623,939 +18% Frazier Life Sciences Public Fund, L.P. 01 Nov 2025
TRVI Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share 7% $77,848,392 -$16,025,200 8,508,021 -17% Frazier Life Sciences Public Fund, L.P. 30 Sep 2025
KALV KALVISTA PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share 6.9% $42,222,226 +$12,986,864 3,466,521 +44% Frazier Life Sciences Public Fund, L.P. 01 Nov 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.7% $3,086,472 -$2,286,600 4,676,472 -43% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
AURA Aura Biosciences, Inc. Common Stock, $0.00001 par value per share 6.3% $20,523,185 +$4,675,216 4,032,060 +30% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
PVLA Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share 6% $70,982,116 +$16,164,419 706,360 +29% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
VOR VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share 5.8% $17,973,688 2,258,001 Frazier Life Sciences Public Fund, L.P. 18 Dec 2025
ERAS Erasca, Inc. Common Stock, $0.0001 par value per share 5.3% $21,355,029 -$10,702,679 15,038,753 -33% Frazier Life Sciences Public Fund, L.P. 30 Jun 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share 5.1% $27,478,154 +$4,642,294 3,698,271 +20% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
JBIO JADE BIOSCIENCES, INC. Common Stock, $0.0001 par value per share 4.2% $11,949,495 +$379,228 1,384,646 +3.3% Frazier Life Sciences Public Fund, L.P. 30 Sep 2025
SVRA Savara Inc. Common Stock, par value $0.001 per share 4.1% $49,390,844 +$9,458,692 8,343,048 +24% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
IRON DISC MEDICINE, INC. Common Stock, par value $0.0001 per share 3% $57,339,676 1,026,489 Frazier Life Sciences Public Fund, L.P. 30 Jun 2025
ORIC ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 2% $7,981,692 1,410,193 James N. Topper 31 Mar 2025
ELDN Eledon Pharmaceuticals, Inc. Common Stock 2% $3,847,923 1,176,735 James N. Topper 31 Dec 2024
ANAB AnaptysBio, Inc. Common Stock 0.5% Frazier Life Sciences Public Fund, L.P. 31 Jan 2025
MGNX MACROGENICS, INC. Common Stock, par value $0.01 per share 0% $0 -$2,804,039 0 -100% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
MREO Mereo BioPharma Group plc Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares 0% $0 -$21,404,255 0 -100% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
ADVM ADVERUM BIOTECHNOLOGIES, INC. Common Stock, $0.0001 par value per share 0% $0 -$18,270,923 0 -100% Frazier Life Sciences Public Fund, L.P. 09 Dec 2025
ELEV Elevation Oncology, Inc. Common stock, par value $0.0001 per share 0% $0 0 Frazier Life Sciences Public Fund, L.P. 23 Jul 2025
ANTX AN2 THERAPEUTICS, INC. Common Stock 0% $0 0 Frazier Life Sciences Public Fund, L.P. 31 Dec 2024
HLVX HILLEVAX, INC. Common Stock, par value $0.0001 per share 0% $0 0 Frazier Life Sciences Public Fund, L.P. 17 Sep 2025
PBYI Puma Biotechnology, Inc. Common Stock 0% $0 0 Frazier Life Sciences Public Fund, L.P. 31 Dec 2024

Schedules 13D/G Reported by Frazier Life Sciences Public Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.